Direct modulation of T-box riboswitch-controlled transcription by protein synthesis inhibitors

Nucleic Acids Res. 2017 Sep 29;45(17):10242-10258. doi: 10.1093/nar/gkx663.

Abstract

Recently, it was discovered that exposure to mainstream antibiotics activate numerous bacterial riboregulators that control antibiotic resistance genes including metabolite-binding riboswitches and other transcription attenuators. However, the effects of commonly used antibiotics, many of which exhibit RNA-binding properties, on the widespread T-box riboswitches, remain unknown. In Staphylococcus aureus, a species-specific glyS T-box controls the supply of glycine for both ribosomal translation and cell wall synthesis, making it a promising target for next-generation antimicrobials. Here, we report that specific protein synthesis inhibitors could either significantly increase T-box-mediated transcription antitermination, while other compounds could suppress it, both in vitro and in vivo. In-line probing of the full-length T-box combined with molecular modelling and docking analyses suggest that the antibiotics that promote transcription antitermination stabilize the T-box:tRNA complex through binding specific positions on stem I and the Staphylococcal-specific stem Sa. By contrast, the antibiotics that attenuate T-box transcription bind to other positions on stem I and do not interact with stem Sa. Taken together, our results reveal that the transcription of essential genes controlled by T-box riboswitches can be directly modulated by commonly used protein synthesis inhibitors. These findings accentuate the regulatory complexities of bacterial response to antimicrobials that involve multiple riboregulators.

Publication types

  • Comparative Study

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Bacterial Proteins / genetics
  • Bacterial Proteins / metabolism
  • Dose-Response Relationship, Drug
  • Gene Expression Regulation, Bacterial / drug effects*
  • Glycine / metabolism
  • Glycine-tRNA Ligase / biosynthesis
  • Glycine-tRNA Ligase / genetics
  • Gram-Negative Bacteria / drug effects
  • Gram-Negative Bacteria / genetics
  • Gram-Negative Bacteria / metabolism
  • Gram-Positive Bacteria / drug effects
  • Gram-Positive Bacteria / genetics
  • Gram-Positive Bacteria / metabolism
  • Models, Molecular
  • Molecular Docking Simulation
  • Nucleic Acid Conformation / drug effects
  • Phylogeny
  • Protein Binding
  • Protein Synthesis Inhibitors / pharmacology*
  • RNA, Bacterial / genetics*
  • RNA, Bacterial / metabolism
  • RNA, Messenger / genetics*
  • RNA, Messenger / metabolism
  • RNA, Transfer / genetics*
  • RNA, Transfer / metabolism
  • RNA, Transfer, Gly / metabolism
  • Recombinant Fusion Proteins / metabolism
  • Riboswitch / drug effects*
  • T-Box Domain Proteins / metabolism
  • Transcription, Genetic / drug effects*

Substances

  • Anti-Bacterial Agents
  • Bacterial Proteins
  • Protein Synthesis Inhibitors
  • RNA, Bacterial
  • RNA, Messenger
  • RNA, Transfer, Gly
  • Recombinant Fusion Proteins
  • Riboswitch
  • T-Box Domain Proteins
  • RNA, Transfer
  • Glycine-tRNA Ligase
  • Glycine